Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

[Reported prevalence of family history of colorectal cancer in the city of Gijon (Spain)].

Ferrero Fernández IE, Echevarría Broz C, Miguel González I, Horta Valvidares M, García González JV.

Semergen. 2012 Nov-Dec;38(8):498-504. doi: 10.1016/j.semerg.2012.02.012. Epub 2012 Jun 6. Spanish.

PMID:
23146702
2.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

3.

The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.

Almog R, Ezra G, Lavi I, Rennert G, Hagoel L.

Eur J Cancer Prev. 2008 Oct;17(5):430-7. doi: 10.1097/CEJ.0b013e328305a0fa.

PMID:
18714185
4.

Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.

Powell AA, Saini SD, Breitenstein MK, Noorbaloochi S, Cutting A, Fisher DA, Bloomfield HE, Halek K, Partin MR.

J Gen Intern Med. 2015 Jun;30(6):732-41. doi: 10.1007/s11606-014-3163-8. Epub 2015 Jan 21.

5.

Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.

Sassoli de Bianchi P, Campari C, Mancini S, Giuliani O, Landi P, Paterlini L, Naldoni C, Finarelli AC, Falcini F, Ponz de Leon M, Sassatelli R, Borciani E, Fornari F, Gatti G, Zatelli M, Zurlini C, Rossi F, Corradini R, Olivetti R, Manfredi M, Baldazzi P, Nannini R, Zanarini S, Matarese VG, Palmonari C, Triossi O, Gordini S, Vattiato R, Colamartini A, Palazzi M, Severi M, Briganti L, Giovanardi M, Casale C, Bucchi L.

Cancer Epidemiol. 2013 Aug;37(4):469-73. doi: 10.1016/j.canep.2013.04.004. Epub 2013 May 14.

PMID:
23683843
6.

Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.

Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A.

Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.

PMID:
19307978
7.

[The populations attitudes to colorectal cancer screening in the Czech Republic].

Král N, Seifert B, Suchánek Š, Zavoral M, Májek O.

Epidemiol Mikrobiol Imunol. 2015 Mar;64(1):41-6. Czech.

PMID:
25872995
8.

Knowledge and attitudes of primary health care physicians and nurses with regard to population screening for colorectal cancer in Balearic Islands and Barcelona.

Ramos M, Esteva M, Almeda J, Cabeza E, Puente D, Saladich R, Boada A, Llagostera M.

BMC Cancer. 2010 Sep 20;10:500. doi: 10.1186/1471-2407-10-500.

9.

Validation of self-reported history of colorectal cancer screening.

Khoja S, McGregor SE, Hilsden RJ.

Can Fam Physician. 2007 Jul;53(7):1192-7.

10.

Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.

Tam TK, Ng KK, Lau CM, Lai TC, Lai WY, Tsang LC.

Hong Kong Med J. 2011 Oct;17(5):350-7.

11.

Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?

Tong S, Hughes K, Oldenburg B, Del Mar C.

Intern Med J. 2004 Sep-Oct;34(9-10):532-8.

PMID:
15482265
12.

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N.

Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28.

13.
14.

Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD.

J Gen Intern Med. 2008 Feb;23(2):169-74. Epub 2007 Dec 21.

15.

Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.

Bampton PA, Sandford JJ, Cole SR, Smith A, Morcom J, Cadd B, Young GP.

Gut. 2005 Jun;54(6):803-6.

16.

Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.

Fraser CG, Matthew CM, Mowat NA, Wilson JA, Carey FA, Steele RJ.

Lancet Oncol. 2006 Feb;7(2):127-31.

PMID:
16455476
17.

Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.

Ellis RJ, Wilson S, Holder RL, McManus RJ.

Eur J Cancer. 2007 Jun;43(9):1437-44. Epub 2007 May 1.

PMID:
17475476
18.

A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.

Multicentre Australian Colorectal-neoplasia Screening (MACS) Group.

Med J Aust. 2006 Jun 5;184(11):546-50.

PMID:
16768659
20.

Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?

Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.

Med Care. 2008 Sep;46(9 Suppl 1):S84-90. doi: 10.1097/MLR.0b013e31817fdf80.

PMID:
18725838

Supplemental Content

Support Center